Biopeak
Overview
Biopeak is a health and wellness company founded in 2024 by Rishi Pardal and Shiva Subramanian. Based in Bengaluru, India, Biopeak focuses on providing personalized health services through its clinics. Employing advanced diagnostics, molecular science, and artificial intelligence, the company addresses early signs of physiological changes and implements tailored health programs. As of June 2025, Biopeak has raised $3.5 million in seed funding from notable investors, including Prashanth Prakash from Accel Partners, Ranjan Pai’s Claypond Capital, and Zerodha co-founder Nikhil Kamath.
Recent Developments
- June 2025: Biopeak secured $3.5 million in seed funding. The investment, led by Accel Partners and Claypond Capital, will be used to expand clinic operations across key Indian cities and strengthen the AI-based diagnostic and care delivery platform.
- March 2025: The company launched its first clinic in Bengaluru, focusing on combining molecular diagnostics with non-invasive testing to detect and address early biological changes. The goal is to implement personalized health plans that maximize healthspan.
- August 2024: Prior to the seed round, Biopeak received $1.43 million in angel funding from Nikhil Kamath, Rainmatter’s investment vehicle. This funding laid the groundwork for Biopeak's diagnostic system and initial clinic setup.
- Biopeak has been collaborating with institutions like the Indian Institute of Science (IISc) and Longevity India to adapt health models specifically for South Asian genetics and environments.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2024 |
| Headquarters | Bengaluru, Karnataka, India |
| Founders | Rishi Pardal, Shiva Subramanian |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | Prashanth Prakash (Accel), Ranjan Pai (Claypond Capital), Nikhil Kamath (Zerodha) |
| Industry | Health and Wellness |
| Number of Employees | 11-50 |
Early History
Biopeak was founded amidst increasing global interest in wellness and longevity solutions. Recognizing a gap in the Indian market for personalized and predictive health services, founders Rishi Pardal and Shiva Subramanian leveraged their expertise in diagnostics and AI to create a company centered on proactive, personalized healthcare. Beginning with initial funding and support from Rainmatter, Biopeak set up its diagnostic framework and established a clinic model designed to deliver individualized health programs. The early focus was on building robust partnerships with leading research institutions to ground their methodologies in sound scientific principles.
Company Profile and Achievements
Biopeak operates by offering highly personalized health services using cutting-edge diagnostics and AI to understand an individual's unique health profile. This involves:
- Developing a range of diagnostics, including genetic analysis, microbiome mapping, and advanced imaging, to create a comprehensive health profile for each client.
- Initiating partnerships with academic and scientific institutions to enhance their healthspan protocols.
- Opening its first state-of-the-art diagnostic and longevity clinic in Bengaluru in March 2025.
- Securing a significant seed funding round to bolster research and operational expansion plans.
- Innovating in AI integration for predictive health diagnostics, with a focus on developing tailored solutions that account for South Asian genetic and environmental factors.
Current Operations and Market Position
Biopeak currently operates primarily in the Indian market, where it's pioneering personalized health diagnostics and longevity treatments. Its business model is centered around clinic-based services that integrate AI-driven diagnostics with traditional health assessments. Biopeak’s competitive edge lies in its focus on predictive medicine and a multi-disciplinary approach, which allows for a comprehensive understanding of patients' health trajectories. This positions Biopeak as a leader in the emerging field of individualized healthspan enhancement in India.
Biopeak Male Enhancement
Biopeak also markets the Biopeak Male Enhancement supplement aimed at boosting stamina and enhancing sexual health. Market reception to these products highlights a trend towards natural solutions in male health, with consumer feedback emphasizing ingredient transparency and efficacy.
Biopeak Capsules
Biopeak offers a range of health supplements, including its Biopeak Capsules, which aim to support general wellness through natural, scientifically-backed ingredients. These products are part of Biopeak's broader strategy to offer comprehensive, personalized health solutions.
Conclusion
Biopeak has established itself as a forward-thinking company at the intersection of health and technology, advocating for a shift from reactive to predictive healthcare. With its focus on personalized diagnostics backed by cutting-edge technology, Biopeak is poised to expand its influence in the health and wellness sector. The company's strategic partnerships and continual expansion efforts suggest a promising trajectory, positioning it as a key player in transforming healthcare delivery in India.